Baerveldt 350 vs Ahmed ClearPath 250 for the Treatment of Glaucoma
NCT04542616
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Glaucoma
Interventions
DEVICE:
Baerveldt 350 vs. Ahmed ClearPath 250 tube shunt implantation
Sponsor
State University of New York at Buffalo